Dow Up 1.64% Nasdaq Up 1.86%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM
1.66 Up 0.11(7.10%) 4:00PM EDT
Prev Close:1.55
Open:1.55
Bid:1.37 x 300
Ask:1.87 x 3100
1y Target Est:3.50
Beta:0.022501
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:1.54 - 1.73
52wk Range:0.80 - 8.96
Volume:393,080
Avg Vol (3m):2,693,170
Market Cap:40.37M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RPRX

Comparison

Symbol% ChgMkt Cap
RPRXUp 7.10%40.37M
ABTUp 2.69%56.67B
AGNUp 1.24%91.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.75
Quarterly EPS Est (Jun-16) :-0.20
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of new drugs to treat hormonal and reproductive system disorders for male and female in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback